Intellia Therapeutics Inc (NTLA)

Currency in USD
12.50
-0.61(-4.65%)
Closed·
After Hours
12.48-0.02(-0.16%)
·

NTLA Earnings

Latest Release
May 08, 2025
EPS / Forecast
-1.10 / -1.27
Revenue / Forecast
16.63M / 12.79M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2025--/-1.03--/11.99M----Free Sign Up
03/2025-1.1/-1.2716.63M/12.79M+13.39%+30.02%Free Sign Up
12/2024-1.27/-1.3412.87M/9.28M+5.22%+38.69%Free Sign Up
09/2024-1.34/-1.399.11M/8.28M+3.6%+10.02%Free Sign Up
06/2024-1.52/-1.226.96M/19.68M-24.59%-64.63%Free Sign Up
03/2024-1.12/-1.3828.94M/10.65M+18.84%+171.74%Free Sign Up
12/2023-1.46/-1.44-1,920,000/12.74M-1.39%-115.07%Free Sign Up
09/2023-1.38/-1.512M/12.45M+8%-3.61%Free Sign Up
06/2023-1.4/-1.3213.6M/12.08M-6.06%+12.58%Free Sign Up
03/2023-1.17/-1.412.61M/11.66M+16.43%+8.15%Free Sign Up

All numbers in USD

Intellia Therapeutics Inc Earnings Call Summary for Q1/2025

  • Intellia Therapeutics beats Q1 2025 estimates: EPS of -$1.10 vs -$1.27 forecast, revenue of $16.63M vs $12.79M expected
  • Stock rises 5.62% premarket to $7.70; company maintains strong liquidity with current ratio of 5.77
  • Cash position at $707.1M, down from $861.7M; expects $95M quarterly cash use with 5-10% YoY decline in GAAP operating expenses
  • Plans first BLA filing in 2026; ATTR cardiomyopathy study enrollment completion targeted for early 2027
  • Exploring non-dilutive financing options; faces competitive pressure in ATTR market and regulatory challenges
Last Updated: 08/05/2025, 14:12
Read Full Transcript

FAQ

What Is Intellia Therapeutics Inc's Earnings Per Share (TTM)?

The Intellia Therapeutics Inc EPS (TTM) is -5.21.

When Is The Next Intellia Therapeutics Inc Earnings Date?

Intellia Therapeutics Inc will release its next earnings report on 30 Jul 2025.

What Is Intellia Therapeutics Inc’s Revenue Forecasts For Upcoming Quarters?

Intellia Therapeutics Inc’s revenue forecast is 11.99M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.